DRUG ABUSE & BEHAVIORAL EXPERIENCE IN HUMANS
DRUG ABUSE & BEHAVIORAL EXPERIENCE IN HUMANS
批准号:
3212739
负责人:
CHRIS-ELLYN JOHANSON
金额:
$9.57万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-01-01 至 1991-12-31
中文摘要
一些人不会成为吸毒者,尽管接触过和
滥用药物的实验。相比之下,其他人似乎
尤其是容易滥用药物的情况下
周围的暴露似乎与非施虐者相当。那里
越来越多的人对确定导致这种情况的因素越来越感兴趣
作为开发更有效的手段的个人脆弱性
预防策略。可能导致易感性的一个因素
某些个体在最初经历不同的影响
接触药物会增加继续使用的可能性。
反复接触这种药物的药理特性可能会
通过其他机制来加剧对它的使用,例如开发物理
依赖。本提案的目标是确定是否
某些行为变量,即普遍的行为条件和
行为体验,可以在人类身上产生不同的药物效果。更多
具体地说,苯丙胺对受罚的影响(点数减法)
响应将在以下项下的响应体验之前和之后进行评估
避免计划(避免积分损失)。先前的动物研究
已经证明,在这种经历之前,苯丙胺减少了
受到惩罚的回应。然而,如果保持回避响应
要么同时发生,要么如果动物有过
作为一种逃避的偶然性,安非他明的影响是巨大的
观察到惩罚反应的改变和增加。中的更改
其他药物的影响作为行为经验的函数
也被发现,但行为经验的影响似乎有限
向滥用毒品致敬。因此,在目前的实验中,
行为经验,以改变马吲哚的效果,一种药物
与安非他明相似但未被滥用的行为特性,也将
要下定决心。如果成功,这项研究将为
在人类中进行行为研究,以确定其他行为是否
与药物滥用更直接相关的影响(例如,歧视性
刺激和强化效果)也可以通过行为改变
经验。此外,证明动物研究可以
在人类身上复制给了人们信心,未来动物在这方面的研究
该区域将与人类相关。
英文摘要
Some individuals do not become drug abusers despite exposure to and
experimentation with drugs of abuse. In contrast, other individuals seem
particularly prone to abusing drugs even when the circumstances
surrounding exposure appear comparable to that of the non-abuser. There
is growing interest in determining factors responsible for this increased
individual vulnerability as a means for developing more effective
prevention strategies. One factor that might contribute to susceptibility
is that certain individuals experience different effects when initially
exposed to a drug that increases the probability of continued use.
Repeated exposure to the pharmacological properties of the drug might then
exacerbate its use by other mechanisms such as the development of physical
dependence. The goal of the present proposal is to determine whether
certain behavioral variables, namely prevailing behavioral conditions and
behavioral experience, can produce different drug effects in humans. More
specifically, the effects of amphetamine on punished (point substraction)
responding will be assessed before and after experience responding under
an avoidance schedule (avoidance of point loss). Previous animal research
has demonstrated that prior to such experience, amphetamine decreases
punished responding. However, if avoidance responding is maintained
either concurrently or if the animal has had a history of responding under
an avoidance contingency, the effects of amphetamine are drastically
altered and increases in punished responding are observed. Alterations in
the effects of other drugs as a function of behavioral experience have
also been found but the influence of behavioral experience appears limited
to drugs of abuse. Thus, in the present experiments, the ability of
behavioral experience to modify effects of mazindol, a drug which has
similar behavioral properties to amphetamine but is not abused, will also
be determined. If successful, this research will open the way for
behavioral research in humans to determine whether other behavioral
effects more directly relevant to drug abuse (e.g., discriminative
stimulus and reinforcing effects) can also be altered by behavioral
experience. In addition, the demonstration that animal studies can be
replicated in humans gives confidence that future animal studies in this
area will be relevant to humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kappa Opioid Antagonist for Cocaine Addiction
-
批准号:7085671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Intravenous Cocaine Discrimination in Humans
-
批准号:6542226
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2002
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Intravenous Cocaine Discrimination in Humans
-
批准号:6612678
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2002
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Intravenous Cocaine Discrimination in Humans
-
批准号:6751687
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2002
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Brain Imaging of Tobacco Craving Using fMRI
-
批准号:6317176
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2001
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Brain Imaging of Tobacco Craving Using fMRI
-
批准号:6515852
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2001
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Brain Imaging of Tobacco Craving Using fMRI
-
批准号:6634343
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2001
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
Brain Imaging of Tobacco Craving Using fMRI
-
批准号:6664829
-
项目类别:
-
资助金额:$6.56万
-
财政年份:2001
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
PHARMACOLOGICAL STUDIES OF BUPRENORPHINE
-
批准号:6332485
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
PHARMACOLOGICAL STUDIES OF BUPRENORPHINE
-
批准号:6300708
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
PHARMACOLOGICAL STUDIES OF BUPRENORPHINE
-
批准号:6201565
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1999
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
PHARMACOLOGICAL STUDIES OF BUPRENORPHINE
-
批准号:6103893
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
PHARMACOLOGICAL STUDIES OF BUPRENORPHINE
-
批准号:6237837
-
项目类别:
-
资助金额:$15.42万
-
财政年份:1997
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
INDIVIDUAL DIFFERENCES IN BIO-BEHAVIORAL DRUG RESPONSE
-
批准号:2898024
-
项目类别:
-
资助金额:$15.06万
-
财政年份:1997
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
INDIVIDUAL DIFFERENCES IN BIO-BEHAVIORAL DRUG RESPONSE
-
批准号:2713136
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1997
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
INDIVIDUAL DIFFERENCES IN BIO-BEHAVIORAL DRUG RESPONSE
-
批准号:2013515
-
项目类别:
-
资助金额:$22.57万
-
财政年份:1997
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
DRUG ABUSE & BEHAVIORAL EXPERIENCE IN HUMANS
-
批准号:3212740
-
项目类别:
-
资助金额:$3.48万
-
财政年份:1990
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
STIMULUS PROPERTIES OF ANXIOLYTICS IN HUMANS
-
批准号:3212662
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1990
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
STIMULUS PROPERTIES OF ANXIOLYTICS IN HUMANS
-
批准号:3212661
-
项目类别:
-
资助金额:$19.92万
-
财政年份:1990
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
MARIJUANA: EFFECTS OF REPEATED SMOKING
-
批准号:3207996
-
项目类别:
-
资助金额:$8.37万
-
财政年份:1984
-
负责人:CHRIS-ELLYN JOHANSON
-
依托单位:
海外基金